An alternative is a “top‐down” approach connecting phenotype to genotype by identifying molecular perturbations in FSHD cells/tissue that correlate with pathology and then investigating the link to the D4Z4 region and/or DUX4. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.